Prescription of selective serotonin reuptake inhibitors 1990-2004

JG Bramness, AM Hausken, S Sakshaug… - Tidsskrift for den …, 2005 - europepmc.org
Background Antidepressant drugs are important in the treatment of major depression. The
use of antidepressants in general and more specifically selective serotonin reuptake …

Escitalopram versus venlafaxine XR in the treatment of depression

SA Montgomery, HF Andersen - International Clinical …, 2006 - journals.lww.com
This article reanalyses and reviews data from the two published randomized clinical trials
comparing escitalopram and venlafaxine XR in the treatment of patients with major …

Pharmacotherapy of mood disorders and treatment discontinuation

M Lader - Drugs, 2007 - Springer
Depression is the most frequent and costly problem in primary care, where most of these
patients are seen and treated. In many countries, the public regard antidepressant drugs as …

Reports of withdrawal syndrome with the use of SSRIs: a case/non‐case study in the French Pharmacovigilance database

T Trenque, D Piednoir, C Frances… - … and Drug Safety, 2002 - Wiley Online Library
The SSRIs can be associated with withdrawal reactions and the objective of this study is to
test the existence of an association between reports of withdrawal syndromes with the …

Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations: findings from a Swedish …

G Isacsson, G Boëthius, S Henriksson, JK Jones… - Journal of Affective …, 1999 - Elsevier
Background: With the advent of the selective serotonin reuptake inhibitors (SSRIs), the use
of antidepressants has increased drastically in Sweden. The use of tricyclic antidepressants …

Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009

E Aguglia, R Ravasio, M Simonetti… - … medical research and …, 2012 - Taylor & Francis
Objectives: This drug utilization study aims to evaluate the incidence and prevalence of
prescribed antidepressants (SSRIs or SNRIs) and to describe treatment modalities in Italy …

Paroxetine for the treatment of depression: a critical update

S Gibiino, A Serretti - Expert Opinion on Pharmacotherapy, 2012 - Taylor & Francis
Introduction: A growth in the market for antidepressants, paired with an ever-increasing
population affected from depressive disorder, requires a critical re-evaluation of most …

Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors

WEE Meijer, ML Bouvy, ER Heerdink… - The British Journal of …, 2001 - cambridge.org
BackgroundIn previous research, lapses in dosing of paroxetine or sertraline were
associated with significantly more discontinuation symptoms and deterioration of depressive …

Paroxetine controlled release

LM Bang, GM Keating - CNS drugs, 2004 - Springer
Abstract▴ A controlled-release (CR) formulation of the SSRI paroxetine has been
developed. This CR formulation delays the release of paroxetine until the tablet has passed …

Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

MMS Stahl, M Lindquist, M Pettersson… - European journal of …, 1997 - Springer
Objective: The present study was performed both to investigate whether there might be a
difference between the selective serotonin re-uptake inhibitors,(SSRIs) with regard to the …